Stockhead on MSN17h
Ozempic’s PBS push could shake up ASX food stocks, and here’s how
Novo Nordisk and Eli Lilly, the companies behind Ozempic, Wegovy, and Mounjaro, have made a request to the Australian government.
Is Novo Nordisk's Bottom Here? Oversold Status Below 10Y P/E Lows
Novo Nordisk faces challenges but its pipeline remains strong. Find out why NVO stock could deliver high double-digit returns ...
Ozempic competitors show there’s much to gain in weight loss drugs
Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment.
More Americans on Ozempic go BLIND as doctors sound alarm over startling side effect
Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...
Reuters13h
U.S. Markets
U.S. Marketscategory Traders now see just one Fed rate cut this year February 7, 2025 U.S. Marketscategory US consumer sentiment drops as inflation expectations surge February 7, 2025 U.S ...
MarketWatch23h
Nike Inc. Cl B
Under Armour Inc. Cl C 1.12% $3.01B Under Armour Inc. Cl A 0.89% $3.01B ...